Quantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria
Abstract Stringent complete response (sCR) is defined as a deeper response than complete response (CR) in multiple myeloma. Whether achieving sCR correlates with better survival remains controversial. We evaluated the outcomes in patients with intact immunoglobulin multiple myeloma (IIMM) and light...
Guardado en:
Autores principales: | Kentaro Narita, Daisuke Miura, Takafumi Tsushima, Toshiki Terao, Ayumi Kuzume, Rikako Tabata, Masami Takeuchi, Kosei Matsue |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8020879372c0409c95c76aeeaeaff2c8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods
por: Takeshi Yoroidaka, et al.
Publicado: (2021) -
Multiple myeloma
por: Larisa P. Mendeleeva, et al.
Publicado: (2021) -
Personalized immunoglobulin aptamers for detection of multiple myeloma minimal residual disease in serum
por: Claudia Tapia-Alveal, et al.
Publicado: (2020) -
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
por: Eileen M. Boyle, et al.
Publicado: (2021) -
Metabolic Disorders in Multiple Myeloma
por: Maria Gavriatopoulou, et al.
Publicado: (2021)